RI-MUHC technology platforms form new partnerships to accelerate research and drug discovery
Partnerships between NMX Research and Solutions, the RI-MUHC...
CTB Technology Platforms Seminar
Biological ‘Nanosphere’ – Biomedical Implications in Cancer and Beyond
CTB Technology Platforms Seminar
Discovering drug leads and chemical biology tools by practical NMR strategies
Alveolar macrophages on patrol for respiratory health
In a study published in Nature, RI-MUHC researchers examine how the lung copes with invading microbes
RI-MUHC and McGill awarded $5.1 million for infectious disease research
A new grant from the Canada Foundation for Innovation will invest in leading edge Containment Level 3...
Instrument Demo – Zeiss Axio Observer 7
Hosted by the Molecular Imaging Platform in collaboration with Zeiss Canada
RI-MUHC trainee Prisca Bustamante honoured by Mitacs Award for Outstanding Innovation
Doctoral student develops world's first non-invasive blood screening test for uveal melanoma
Multiplexed technologies are paving the way to rapid and equitable screening for sexually transmitted infections
Work by RI-MUHC postdoc Angela Karellis published in The Lancet...
RI-MUHC team detects impact of HIV antiretroviral therapy on the anti-tuberculosis immune response
Alveolar macrophages, cells important for protection from tuberculosis infection, are adversely impacted by...